Mediclinic International plc (ANHGY) Stock

About Mediclinic International plc

Mediclinic International plc, through its various group entities, manages and operates private healthcare facilities, delivering comprehensive, specialist-driven, and diverse medical care under the Mediclinic and Hirslanden brand names. Its extensive network spans Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom, encompassing 74 hospitals, 20 day clinics, 22 outpatient centers, 5 subacute care facilities, and 2 mental health institutions. These operations include 453 operating theatres and provide approximately 11,538 inpatient beds. Beyond direct patient care, the company engages in a broad array of supporting functions, such as treasury operations, sourcing and managing hospital equipment, providing emergency medical aid, general management services, food and catering, overall healthcare management, and debt collection. It also oversees healthcare personnel and manages its real estate holdings. Furthermore, its activities extend to managing intellectual property and operating medical supply and procurement ventures. Established in 1983, Mediclinic International plc is headquartered in Stellenbosch, South Africa.

Mediclinic International plc is headquartered in ZA.

Mediclinic International plc (ANHGY) stock trades at $5.49 with a market capitalization of $4.05B. The stock is valued at a price-to-earnings (P/E) ratio of 25.62, price-to-book of 1.28, price-to-sales of 123.98. Over the past 52 weeks the stock has ranged between $4.62 and $5.58, and currently trades 1.6% below its 52-week high.

On profitability, Mediclinic International plc generates a return on equity (ROE) of 5.07%, return on capital employed of 4.39%, an operating margin of 8.66%, a net profit margin of 4.67%.

Official website: www.mediclinic.com